How GCV Labs and GCV Invest work together

Growth Capital Ventures does two things that are usually done by two different kinds of organisation. It builds companies, through GCV Labs. And it makes investment opportunities available to investors, through GCV Invest. Those two capabilities support each other, but they are deliberately not the same business — and for anyone considering investing, understanding where the line falls is more useful than any amount of ecosystem language.

Build and fund

That last row is the one that matters most and is most often glossed over elsewhere. GCV Labs is a venture builder. It does not promote, arrange or advise on investments. Where an investment opportunity exists in a Growth Capital Ventures company, it is made available through GCV Invest, to investors who meet the relevant qualifying criteria, with the disclosures and processes that regulated activity requires. Nothing on the GCV Labs site is an offer or an invitation to invest.

Why the two are stronger together

Most venture builders eventually need a route to capital, and most investment platforms eventually wish they had more influence over the quality of what they see. Having both under one ecosystem changes the quality of each.

What it looked like in practice

Intelligence Fusion is the clearest illustration. GCV Labs co-founded the business with Michael McCabe and ran the full venture build — proposition, product, technology, brand, team. Early capital came from the GCV Invest network, at a point where the evidence was promising rather than proven. As the platform found product-market fit and demonstrated its revenue model, institutional core investors came in behind that evidence. GCV Labs remained operationally engaged throughout, including an interim chairman role. The business was ultimately acquired by Sigma7, backed by Growth Catalyst Partners, and the platform continues as part of S7 One.

Read the sequence again and note what each party did. The builder created the company and stayed with it. The network funded the stage that institutions would not have. The institutions funded the stage the network could not. Each played the role it was suited to, in the order the evidence allowed. The full case study covers the journey stage by stage.

Who invests, and at what point

Different investors are suited to different stages, and one of the practical advantages of a staged build is that it is clear which is which.

• Private investors, through GCV Invest, typically at earlier stages where SEIS or EIS qualification is more commonly relevant.
• Institutional investors and co-investors, typically once a product is in market and a revenue model is evidenced.
• Corporate investors, where the venture is being built with or alongside an established business and the stake is strategic as well as financial.

The investor page sets out those three routes in more detail, alongside the typical funding values attached to each stage of the process.

What this is not

It is worth being explicit. The ecosystem does not guarantee that a GCV Labs venture will be funded, that a GCV Invest investor will be offered every opportunity, or that a built company will succeed. Early-stage investment remains high risk and illiquid, capital is at risk, and past outcomes in the portfolio are not an indication of future results. What the structure offers is coherence: a company created through a defined process, funded by investors who understand what stage it is at, supported by a team that does not disappear at completion.

If you want the underlying argument for why building and backing are different activities in the first place, venture builder vs venture capital sets it out. If you want the investor's view of what the build removes from the risk, start with why invest in venture-built companies.